84742Toplam
8Olumlu
8Olumsuz
34Nötr
Piyasa:
Tümü
🇹🇷 BIST
Kripto
🇺🇸 ABD
🇰🇿 KASE
🇪🇬 EGX
🇸🇾 DSE
🇸🇦 Tadawul
🇦🇪 DFM
🇶🇦 QSE
🇷🇺 MOEX
🇬🇧 LSE
🇩🇪 Xetra
🇪🇺 Euronext
🇸🇪 Nordic
🇲🇦 CSE
🇯🇴 ASE
BRVM
🇮🇳 India
🇭🇰 HKEX
🇰🇷 KRX
🇿🇦 JSE
🇦🇺 ASX
🇧🇷 B3
🇹🇼 TWSE
🇸🇬 SGX
🇨🇳 China
🇯🇵 Japan
Sayfa 74 / 1695 · toplam 84742 haber
▲
2 Cryptocurrencies Poised to Surge 100% in the Coming Years That Savvy Investors Are Already Buying
Bu özet yapay zekâ ile otomatik üretildi
It can make sense to check out what big investors are doing with their money.
—
Zymeworks EVP Adam Schayowitz sells $357,557 in ZYME stock for taxes
Bu özet yapay zekâ ile otomatik üretildi
Zymeworks EVP Adam Schayowitz sells $357,557 in ZYME stock for taxes
—
Key deals this week: Option Care Health, PTC, Energy Transfer and more
Bu özet yapay zekâ ile otomatik üretildi
Key deals this week: Option Care Health, PTC, Energy Transfer and more
—
Russia Lifts Ban on Diesel Exports as Part of Trump-Putin Deal - Bloomberg.com
Bu özet yapay zekâ ile otomatik üretildi
Russia Lifts Ban on Diesel Exports as Part of Trump-Putin Deal Bloomberg.com
—
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH
Bu özet yapay zekâ ile otomatik üretildi
VanEck's lower 0.35% expense ratio appeals to cost-conscious investors, while First Trust's $2.9 billion in assets and equal-weighted approach offer broader diversification across 30 biotech holdings.
—
Could $1,000 Invested in Bitcoin Help You Retire a Millionaire?
Bu özet yapay zekâ ile otomatik üretildi
At one time, Bitcoin had 1,000x upside potential.
—
CEO Tom Ward Acquires 172,000 Mach Natural Resources Units for $2.0 Million. Is the Oil Boom a Gusher for the Stock?
Bu özet yapay zekâ ile otomatik üretildi
Ward's purchase through his revocable trust brings his aggregate stake to 28.4 million units, representing a 17.0% ownership interest in the energy partnership.
—
SkyAI 10% owner Bastion Trading buys $78,262 in SKYA stock
Bu özet yapay zekâ ile otomatik üretildi
SkyAI 10% owner Bastion Trading buys $78,262 in SKYA stock
—
Coupang vs. MercadoLibre: Which Consumer Stock Is a Better Buy in 2026?
Bu özet yapay zekâ ile otomatik üretildi
Coupang trades at a fraction of MercadoLibre's sales multiple, but the Latin American fintech giant generates far superior margins and cash flow.
—
Appian CEO Matthew Calkins sells $1.69m in company stock
Bu özet yapay zekâ ile otomatik üretildi
Appian CEO Matthew Calkins sells $1.69m in company stock
▼
History Says Abbott Stock Could More Than Double by 2036. Here’s Why I Just Added It to My Portfolio.
Bu özet yapay zekâ ile otomatik üretildi
Abbott has a low-risk profile with significant upside potential.
—
Silver ETF Faceoff: Will SLV or SIL Give You Better Exposure to the Shiny Metal?
Bu özet yapay zekâ ile otomatik üretildi
iShares Silver Trust offers lower fees and $30.5B in assets, while Global X Silver Miners ETF delivers dividend income and operational leverage from mining companies.
▲
3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices
Bu özet yapay zekâ ile otomatik üretildi
Tilray's stock isn't the bargain it appears to be at first.
▲
The Nasdaq-100 Has Gained 20% or More 3 Years Running. This Streak Rests on Far Stronger Earnings Than 1999's.
Bu özet yapay zekâ ile otomatik üretildi
The two earlier streaks like it both ended with a down year of over 30%.
—
China passenger vehicle retail market slumps 24% in September
Bu özet yapay zekâ ile otomatik üretildi
China passenger vehicle retail market slumps 24% in September
—
Infosys, ABD PERM askıya alınmasından maddi etki beklemiyor
Bu özet yapay zekâ ile otomatik üretildi
Infosys, ABD PERM askıya alınmasının işe alım ve gelir üzerinde maddi etkisi olmayacağını belirtti.
—
Banco Bradesco's Head of PE and VC Purchases $1.7 Million Shares. Does This Signal the Brazilian Bank Is a Buy?
Bu özet yapay zekâ ile otomatik üretildi
Roberto De Jesus Paris expanded his direct stake by 36%, signaling confidence in the Brazilian bank's equity despite a modest one-year return.
—
CrowdStrike vs. UiPath: Which Technology Stock Is a Better Buy in 2026?
Bu özet yapay zekâ ile otomatik üretildi
CrowdStrike trades at a steep premium despite ongoing profitability challenges, while UiPath has just turned profitable with a valuation multiple a fraction of its rival's.
—
Everpure director Mallun Yen sells $1.75m in shares
Bu özet yapay zekâ ile otomatik üretildi
Everpure director Mallun Yen sells $1.75m in shares
—
Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock
Bu özet yapay zekâ ile otomatik üretildi
Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock
—
Pacific Biosciences CFO reports $2.05m stock sale
Bu özet yapay zekâ ile otomatik üretildi
Pacific Biosciences CFO reports $2.05m stock sale
—
1 Reason the Meta Muse AI Agent Has the Upper Hand
Bu özet yapay zekâ ile otomatik üretildi
Investors should be thinking about monetization strategies.
—
Here's What History Says October Will Bring for Nike Stock
Bu özet yapay zekâ ile otomatik üretildi
Shares have moved lower by 3% so far this month.
▼
Better Pharma ETF: iShares IHE vs. State Street XPH
Bu özet yapay zekâ ile otomatik üretildi
IHE concentrates 23.6% in Eli Lilly and delivers 1.4% yield, while XPH spreads risk across 62 holdings with a lower 0.35% expense ratio.
—
Here's the 1 Thing I'd Wait to See Before Buying SpaceX Stock.
Bu özet yapay zekâ ile otomatik üretildi
SpaceX must prove its AI spending is worth the near-term pain.
—
Analog devices director Ray Stata sells $1.17 million in shares
Bu özet yapay zekâ ile otomatik üretildi
Analog devices director Ray Stata sells $1.17 million in shares
—
Pimco high income fund director David Flattum buys $249,245 stock
Bu özet yapay zekâ ile otomatik üretildi
Pimco high income fund director David Flattum buys $249,245 stock
—
Pimco Dynamic Income Fund director David Flattum buys $249,508 in shares
Bu özet yapay zekâ ile otomatik üretildi
Pimco Dynamic Income Fund director David Flattum buys $249,508 in shares
—
EU-China trade relations hit crunch time as Brussels pushes for rebalancing
Bu özet yapay zekâ ile otomatik üretildi
EU-China trade relations hit crunch time as Brussels pushes for rebalancing
—
Joby Just Flew an Aircraft Across the United States With No Pilot. Here's Why Wall Street Shrugged.
Bu özet yapay zekâ ile otomatik üretildi
Joby's technology impressed, but Wall Street is waiting for revenue.
—
Advanced Micro Devices vs. Qualcomm: Which Technology Stock Is a Better Buy in 2026?
Bu özet yapay zekâ ile otomatik üretildi
AMD's net margin doubled while Qualcomm trades at a fraction of its rival's valuation, but customer concentration and competitive threats complicate both bets.
—
Mueller Water Products director Healy buys $29,927 in shares
Bu özet yapay zekâ ile otomatik üretildi
Mueller Water Products director Healy buys $29,927 in shares
▼
The Best Stock to Invest $10,000 in Right Now
Bu özet yapay zekâ ile otomatik üretildi
If I had $10,000 to put into one consumer stock right now, this fast-growing coffee chain would be it, even with real risk attached.
▲
Could Buying This 1 Cryptocurrency Make You Rich?
Bu özet yapay zekâ ile otomatik üretildi
NEAR Protocol is soaring in value this year, but how long can it keep up this performance?
▲
Is SoundHound AI a Buy After the LivePerson Deal?
Bu özet yapay zekâ ile otomatik üretildi
SoundHound's story has changed.
—
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma
Bu özet yapay zekâ ile otomatik üretildi
BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical holdings.
—
Philips investors’ move to probe company over 2021 recall denied by Dutch court
Bu özet yapay zekâ ile otomatik üretildi
Philips investors’ move to probe company over 2021 recall denied by Dutch court
▼
Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock?
Bu özet yapay zekâ ile otomatik üretildi
Viking's weight loss pill program has a couple of issues, including the fierce competitors who have a big head start.
—
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Bu özet yapay zekâ ile otomatik üretildi
Bristol Myers Squibb trades at a steeper discount despite higher leverage, while Novo Nordisk commands a premium on exceptional profitability and GLP-1 dominance.
—
AST SpaceMobile Has $3.7 Billion in Liquidity and No Commercial Revenue. Here's How to Value That.
Bu özet yapay zekâ ile otomatik üretildi
The LEO satellite developer still has plenty of upside potential.
▼
Why ExxonMobil's Venezuela Warning Could Matter for Energy Investors Right Now
Bu özet yapay zekâ ile otomatik üretildi
ExxonMobil's pragmatic approach to Venezuela could reward investors, regardless of how much oil the company does or doesn't pump there.
▲
Real estate stocks outperform broader markets
Bu özet yapay zekâ ile otomatik üretildi
Real estate stocks outperform broader markets
—
908 devices CFO Joseph Griffith sells $65,150 in common stock
Bu özet yapay zekâ ile otomatik üretildi
908 devices CFO Joseph Griffith sells $65,150 in common stock
▲
Star Bulk Carriers Director Karellis Purchases 2,000 Shares for $56,540. Is This a Signal The Cargo Rate Boom Continues?
Bu özet yapay zekâ ile otomatik üretildi
Karellis increased his direct holdings by 26%, signaling confidence in the shipping company as its stock surges 61% over the past year.
—
Expectations of Another Fed Rate Hike This Month Are Shifting Dramatically
Bu özet yapay zekâ ile otomatik üretildi
Suddenly, it appears the Fed may hit pause on rate hikes in October.
—
Cathie Wood Just Cut Her SpaceX Position. Is It Time to Sell?
Bu özet yapay zekâ ile otomatik üretildi
Cathie Wood loves SpaceX, but her firm sold some of its shares this week.
▲
Like Meta's Muse AI Agents? 4 AI Semiconductor Stocks Set to Benefit From the Rise of AI Agents.
Bu özet yapay zekâ ile otomatik üretildi
The data center CPU market looks set to explode.
▼
Broadcom vs. Intel: Which Chip Stock Is a Better Buy in 2026?
Bu özet yapay zekâ ile otomatik üretildi
Broadcom's 36% net margin and dominant AI accelerator position contrast sharply with Intel's foundry turnaround and negative free cash flow.
▼
Want to Retire on Dividends? Here Are 4 Stocks to Buy Now and Never Sell.
Bu özet yapay zekâ ile otomatik üretildi
These consumer staples sell everyday brands that have funded decades of consistent dividends.
▼
Insider trades: P&G, Marvell Technology, TSMC among notable names
Bu özet yapay zekâ ile otomatik üretildi
Insider trades: P&G, Marvell Technology, TSMC among notable names
Sayfa 74 / 1695 · toplam 84742 haber